全文获取类型
收费全文 | 793203篇 |
免费 | 82332篇 |
国内免费 | 236篇 |
出版年
2018年 | 7938篇 |
2017年 | 7588篇 |
2016年 | 10648篇 |
2015年 | 13462篇 |
2014年 | 16038篇 |
2013年 | 23164篇 |
2012年 | 26012篇 |
2011年 | 26789篇 |
2010年 | 18289篇 |
2009年 | 16928篇 |
2008年 | 23952篇 |
2007年 | 24916篇 |
2006年 | 23298篇 |
2005年 | 22416篇 |
2004年 | 22194篇 |
2003年 | 21345篇 |
2002年 | 20838篇 |
2001年 | 34725篇 |
2000年 | 34183篇 |
1999年 | 27401篇 |
1998年 | 9846篇 |
1997年 | 9912篇 |
1996年 | 9508篇 |
1995年 | 9051篇 |
1994年 | 8722篇 |
1993年 | 8756篇 |
1992年 | 22349篇 |
1991年 | 21935篇 |
1990年 | 21367篇 |
1989年 | 20821篇 |
1988年 | 19091篇 |
1987年 | 18332篇 |
1986年 | 17091篇 |
1985年 | 16949篇 |
1984年 | 13930篇 |
1983年 | 12177篇 |
1982年 | 9232篇 |
1981年 | 8353篇 |
1980年 | 7750篇 |
1979年 | 12935篇 |
1978年 | 10199篇 |
1977年 | 9190篇 |
1976年 | 8798篇 |
1975年 | 9813篇 |
1974年 | 10485篇 |
1973年 | 10348篇 |
1972年 | 9470篇 |
1971年 | 8452篇 |
1970年 | 7382篇 |
1969年 | 7256篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
41.
Huie M. J.; Casazza G. A.; Horning M. A.; Brooks G. A. 《Journal of applied physiology》1996,80(5):1554-1559
42.
43.
This is the first report of the growth in culture of Porphyra subtumens J. Agardh ex Laing (Bangiales, Rhodophyta), an obligate epiphyte of Durvillaea species and endemic to New Zealand waters. Archeospores, previously observed on field material, develop directly into the blade phase. Spores released from field collected blades form conchocelis. Conchospores develop into new blades, completing the life history in culture. Earlier reports of reproduction in P. subtumens gave conflicting accounts with some authors citing this species as having an asexual, monophasic life history with an unusual form of spore production, while others described spermatangia and carposporangia on the blade phase. 相似文献
44.
45.
46.
47.
48.
Chungwen Wei Eugene Storozynsky A. J. McAdam Kun-Yun Yeh Brian R. Tilton Richard A. Willis Richard K. Barth R. John Looney Edith M. Lord J. G. Frelinger 《Cancer immunology, immunotherapy : CII》1996,42(6):362-368
Human prostate-specific antigen (PSA) has a highly restricted tissue distribution. Its expression is essentially limited
to the epithelial cells of the prostate gland. Moreover, it continues to be synthesized by prostate carcinoma cells. This
makes PSA an attractive candidate for use as a target antigen in the immunotherapy of prostate cancer. As a first step in
characterizing the specific immune response to PSA and its potential use as a tumor-rejection antigen, we have incorporated
PSA into a well-established mouse tumor model. Line 1, a mouse lung carcinoma, and P815, a mouse mastocytoma, have been transfected
with the cDNA for human PSA. Immunization with a PSA-expressing tumor cell line demonstrated a memory response to PSA which
protected against subsequent challenge with PSA-expressing, but not wild-type, tumors. Tumor-infiltrating lymphocytes could
be isolated from PSA-expressing tumors grown in naive hosts and were specifically cytotoxic against a syngeneic cell line
that expressed PSA. Immunization with tumor cells resulted in the generation of primary and memory cytotoxic T lymphocytes
(CTL) specific for PSA. The isolation of PSA-specific CTL clones from immunized animals further demonstrated that PSA can
serve as a target antigen for antitumor CTL. The immunogenicity studies carried out in this mouse tumor model provide a rationale
for the design of methods to elicit PSA-specific cell-mediated immunity in humans.
Received: 4 April 1996 / Accepted: 31 May 1996 相似文献
49.
50.